Stay updated on COMBI-i Clinical Trial: Anti-PD1 + Dabrafenib/Trametinib
Sign up to get notified when there's something new on the COMBI-i Clinical Trial: Anti-PD1 + Dabrafenib/Trametinib page.

Latest updates to the COMBI-i Clinical Trial: Anti-PD1 + Dabrafenib/Trametinib page
- Check3 days agoChange DetectedThe site footer revision label changes from v3.7.1 to v3.7.2.SummaryDifference0.0%

- Check10 days agoChange DetectedThe ClinicalTrials.gov site revision changed from v3.7.0 to v3.7.1.SummaryDifference0.0%

- Check17 days agoNo Change Detected
- Check31 days agoChange DetectedA new revision entry, v3.7.0, appears in the history replacing the previous v3.6.6; this reflects an update to the page's history rather than a change to the study data.SummaryDifference0.0%

- Check52 days agoChange DetectedThe page’s revision indicator in the footer was updated from v3.6.5 to v3.6.6, signaling a small maintenance update to the page version. No user-facing content changes are introduced.SummaryDifference0.0%

- Check74 days agoChange DetectedThe page now reflects a software revision bump from v3.6.4 to v3.6.5, indicating an update to the underlying platform. This change represents a backend/version upgrade rather than a modification to study information shown on the page.SummaryDifference0.0%

- Check88 days agoChange DetectedThe history entry now shows Revision: v3.6.4 in place of v3.6.3. This updates the revision tag displayed for the study record on the history page.SummaryDifference0.0%

Stay in the know with updates to COMBI-i Clinical Trial: Anti-PD1 + Dabrafenib/Trametinib
Enter your email address, and we'll notify you when there's something new on the COMBI-i Clinical Trial: Anti-PD1 + Dabrafenib/Trametinib page.